Clinical Trial

OST and MORES in Male Osteoporosis

Study acronym: OST and MORES
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to compare the Male Osteoporosis Risk Score and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in male individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of male osteoporosis.
Trial Details
NCT Number NCT07518212
Lead Sponsor Kayseri City Hospital
Conditions Male Osteoporosis
Enrollment 140 participants
Start Date 2026-02-04
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-08